Regeneron Pharmaceuticals, Inc. vs Wesfarmers Limited
Market cap comparison over time
Regeneron Pharmaceuticals, Inc.
$63.0B
Rank #231
Wesfarmers Limited
$63.9B
Rank #229
Market Cap Over Time
Key Moments
- Regeneron Pharmaceuticals, Inc. overtook Wesfarmers Limited by 1995
- Wesfarmers Limited overtook Regeneron Pharmaceuticals, Inc. by 1997
- Regeneron Pharmaceuticals, Inc. overtook Wesfarmers Limited by 1999
- Wesfarmers Limited overtook Regeneron Pharmaceuticals, Inc. by 2001
- Regeneron Pharmaceuticals, Inc. overtook Wesfarmers Limited by 2012
- Wesfarmers Limited overtook Regeneron Pharmaceuticals, Inc. by 2026
Year-by-Year Comparison
| Year | Regeneron Pharmaceuticals, Inc. | Wesfarmers Limited | Leader |
|---|---|---|---|
| 2026 | $63.0B | $63.9B | Wesfarmers Limited |
| 2025 | $79.3B | $59.1B | Regeneron Pharmaceuticals, Inc. |
| 2024 | $72.8B | $50.9B | Regeneron Pharmaceuticals, Inc. |
| 2023 | $89.7B | $39.4B | Regeneron Pharmaceuticals, Inc. |
| 2022 | $73.7B | $30.6B | Regeneron Pharmaceuticals, Inc. |
| 2021 | $64.5B | $38.0B | Regeneron Pharmaceuticals, Inc. |
| 2020 | $49.4B | $30.3B | Regeneron Pharmaceuticals, Inc. |
| 2019 | $38.4B | $24.0B | Regeneron Pharmaceuticals, Inc. |
| 2018 | $38.2B | $17.3B | Regeneron Pharmaceuticals, Inc. |
| 2017 | $38.4B | $15.8B | Regeneron Pharmaceuticals, Inc. |
| 2016 | $37.5B | $13.9B | Regeneron Pharmaceuticals, Inc. |
| 2015 | $55.5B | $12.9B | Regeneron Pharmaceuticals, Inc. |
| 2014 | $41.9B | $12.1B | Regeneron Pharmaceuticals, Inc. |
| 2013 | $28.1B | $12.0B | Regeneron Pharmaceuticals, Inc. |
| 2012 | $17.5B | $9.6B | Regeneron Pharmaceuticals, Inc. |
| 2011 | $5.7B | $7.1B | Wesfarmers Limited |
| 2010 | $3.4B | $7.2B | Wesfarmers Limited |
| 2009 | $2.5B | $6.7B | Wesfarmers Limited |
| 2008 | $1.9B | $3.4B | Wesfarmers Limited |
| 2007 | $2.5B | $6.8B | Wesfarmers Limited |
| 2006 | $2.1B | $5.8B | Wesfarmers Limited |
| 2005 | $1.6B | $5.2B | Wesfarmers Limited |
| 2004 | $941.1M | $5.3B | Wesfarmers Limited |
| 2003 | $1.5B | $2.9B | Wesfarmers Limited |
| 2002 | $1.9B | $2.7B | Wesfarmers Limited |
| 2001 | $2.9B | $3.0B | Wesfarmers Limited |
| 2000 | $3.6B | $1.5B | Regeneron Pharmaceuticals, Inc. |
| 1999 | $1.3B | $1.1B | Regeneron Pharmaceuticals, Inc. |
| 1998 | $753.6M | $1.1B | Wesfarmers Limited |
| 1997 | $874.9M | $912.0M | Wesfarmers Limited |
| 1996 | $1.6B | $583.1M | Regeneron Pharmaceuticals, Inc. |
| 1995 | $1.3B | $510.9M | Regeneron Pharmaceuticals, Inc. |
| 1994 | $306.5M | $471.6M | Wesfarmers Limited |